To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to facilitate the development and approval of new drugs and biological products, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
105th Congress (1997–1998)
This bill was introduced in a previous session of Congress and was passed by the House on October 7, 1997 but was never passed by the Senate.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
16 Cosponsors (12 Republicans, 4 Democrats)
Position statements
History
|
Apr 23, 1997
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Sep 24, 1997
|
|
Alternative Bill —
Passed Senate (House next)
This activity took place on a related bill, S. 830 (105th), possibly in lieu of similar activity on H.R. 1411 (105th). |
|
Sep 25, 1997
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Oct 7, 1997
|
|
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.
|
|
Oct 7, 1997
|
|
Alternative Bill —
Passed House
This activity took place on a related bill, S. 830 (105th), possibly in lieu of similar activity on H.R. 1411 (105th). |
|
Nov 9, 1997
|
|
Alternative Bill —
Conference Report Agreed to by Senate (House next)
This activity took place on a related bill, S. 830 (105th), possibly in lieu of similar activity on H.R. 1411 (105th). |
|
Nov 9, 1997
|
|
Alternative Bill —
Conference Report Agreed to by House
This activity took place on a related bill, S. 830 (105th), possibly in lieu of similar activity on H.R. 1411 (105th). |
|
Nov 21, 1997
|
|
Alternative Bill —
Enacted — Signed by the President
This activity took place on a related bill, S. 830 (105th), possibly in lieu of similar activity on H.R. 1411 (105th). |
H.R. 1411 (105th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 1411. This is the one from the 105th Congress.
This bill was introduced in the 105th Congress, which met from Jan 7, 1997 to Dec 19, 1998. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 1411 — 105th Congress: Food and Drug Administration Regulatory Modernization Act of 1997.” www.GovTrack.us. 1997. March 27, 2023 <https://www.govtrack.us/congress/bills/105/hr1411>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
